Borealis is deeply rooted in the Dartmouth College community and uniquely committed to partnering with Dartmouth researchers, students and alumni around the world in building businesses to commercialize their innovations.
Avitide, Inc., the leader in the discovery, manufacture, and supply of novel affinity purification solutions for the biopharmaceutical industry, closed its Series D financing. Mithril Capital Management, LLC led the financing round. Avitide rapidly and [...]
Adimab LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced a multi-target partnership with Takeda Pharmaceutical Company Ltd. Under the terms of the agreement, Adimab will [...]
Avedro, Inc., an ophthalmic pharmaceutical and medical device company, has received approval from the U.S. Food and Drug Administration (FDA) for Photrexa Viscous, Photrexa and the KXL System. Photrexa Viscous and Photrexa are photoenhancers indicated [...]
The offices of Adimab, a biotech company in Lebanon, New Hampshire, smell pleasantly of fresh bread. It’s an olfactory illusion, albeit a welcome one. Nobody is baking anything. The laboratory is lined with beaker after [...]
"I’ve worked with Borealis on multiple startups, including Adimab, Avitide, and Compass, and can attest to the firm’s crucial role in helping Dartmouth entrepreneurs build their companies as the trusted and local early-stage investor. The Borealis team are dedicated and thoughtful partners who align themselves with founders and support their vision."
COO and Co-Founder, Compass
Founder, Adimab, Avitide
We’re always interested in engaging with inventors, creators, and entrepreneurs to help develop ideas and realize visions.